Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for A5D7I4

Entry ID Method Resolution Chain Position Source
AF-A5D7I4-F1 Predicted AlphaFoldDB

116 variants for A5D7I4

Variant ID(s) Position Change Description Diseaes Association Provenance
rs475059623 30 A>E No EVA
rs453268619 32 R>K No EVA
rs458894073 35 S>C No EVA
rs473293139 36 R>L No EVA
rs438623771 40 H>P No EVA
rs458711242 41 S>R No EVA
rs475526341 42 G>C No EVA
rs480859753 47 H>D No EVA
rs439956294 47 H>P No EVA
rs480859753 47 H>Y No EVA
rs477466551 60 D>E No EVA
rs446218863 61 A>D No EVA
rs469572811 70 Q>E No EVA
rs483249628 75 D>V No EVA
rs448602490 81 S>P No EVA
rs434016719 93 Y>* No EVA
rs454078962 101 E>D No EVA
rs466880585 102 S>Y No EVA
rs432214923 103 C>G No EVA
rs452237351 104 F>V No EVA
rs475677054 106 F>Y No EVA
rs444180419 119 Y>F No EVA
rs474460488 142 R>G No EVA
rs439970375 142 R>S No EVA
rs459941206 143 F>V No EVA
rs477527891 155 V>D No EVA
rs439912092 156 L>V No EVA
rs448580871 177 K>E No EVA
rs468674736 184 W>* No EVA
rs447700530 188 R>S No EVA
rs464533109 189 N>D No EVA
rs452417586 191 L>F No EVA
rs469248477 195 L>F No EVA
rs437792749 197 S>A No EVA
rs454535418 200 W>* No EVA
rs440033684 207 V>E No EVA
rs470443418 214 A>T No EVA
rs439175429 216 L>P No EVA
rs463313298 217 A>T No EVA
rs442218720 220 S>G No EVA
rs479131669 223 T>N No EVA
rs447819601 226 F>I No EVA
rs458218930 227 R>L No EVA
rs437852056 250 F>V No EVA
rs448212570 251 L>W No EVA
rs468234473 253 F>V No EVA
rs433736836 277 S>A No EVA
rs475866350 282 A>V No EVA
rs453720397 307 H>P No EVA
rs470670084 312 C>S No EVA
rs456028242 313 D>G No EVA
rs432772034 313 D>H No EVA
rs443416038 315 D>G No EVA
rs465590888 322 Y>N No EVA
rs797605418 459 S>A No EVA
rs1115136220 480 F>I No EVA
rs469334145 482 A>T No EVA
rs876481324 484 I>T No EVA
rs876597962 485 H>P No EVA
rs483179155 485 H>Q No EVA
rs448535152 487 V>G No EVA
rs468574239 488 T>P No EVA
rs433927069 490 L>R No EVA
rs876347347 494 S>P No EVA
rs453235926 499 K>N No EVA
rs522802649 502 V>M No EVA
rs466860078 505 A>V No EVA
rs478653943 517 W>* No EVA
rs447398403 518 N>I No EVA
rs464122325 520 D>E No EVA
rs477693405 521 K>N No EVA
rs469801525 526 K>N No EVA
rs435135306 527 H>P No EVA
rs456172544 529 W>C No EVA
rs474014239 568 T>I No EVA
rs478976358 575 V>G No EVA
rs477104997 576 D>Y No EVA
rs440302165 592 Y>D No EVA
rs445121825 686 T>I No EVA
rs465199648 687 S>C No EVA
rs436968907 688 R>Q No EVA
rs457076073 690 S>F No EVA
rs473883922 692 W>* No EVA
rs436044991 693 A>P No EVA
rs452876623 695 P>A No EVA
rs439102514 700 Q>H No EVA
rs452673167 703 S>R No EVA
rs475836686 707 T>P No EVA
rs461317995 708 F>C No EVA
rs444593714 708 F>I No EVA
rs444593714 708 F>V No EVA
rs481571229 710 S>C No EVA
rs440468815 710 S>R No EVA
rs460572318 718 I>N No EVA
rs477432930 719 H>R No EVA
rs445183341 721 Q>R No EVA
rs465262738 723 R>S No EVA
rs482057739 724 L>M No EVA
rs450729023 725 D>A No EVA
rs467495670 726 P>S No EVA
rs452893408 732 Q>H No EVA
rs466618509 733 V>D No EVA
rs466618509 733 V>G No EVA
rs431932934 734 S>F No EVA
rs452736612 735 I>L No EVA
rs444657037 739 K>E No EVA
rs454998077 740 Y>C No EVA
rs454998077 740 Y>F No EVA
rs475176817 741 R>G No EVA
rs460581017 743 I>F No EVA
rs460581017 743 I>L No EVA
rs477486292 743 I>T No EVA
rs462913616 744 E>D No EVA
rs439624344 744 E>G No EVA
rs450790257 746 L>H No EVA
rs467606023 747 L>C No EVA

2 associated diseases with A5D7I4

[MIM: 613861]: Retinitis pigmentosa 59 (RP59)

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:21295283}. Note=The disease is caused by variants affecting the gene represented in this entry.

[MIM: 617836]: Developmental delay and seizures with or without movement abnormalities (DEDSM)

An autosomal dominant neurodevelopmental disorder characterized by global developmental delay, variable intellectual disability, and early-onset seizures with a myoclonic component. Most patients have delayed motor development and show abnormal movements, including ataxia, dystonia, and tremor. {ECO:0000269|PubMed:29100083}. Note=The disease may be caused by variants affecting the gene represented in this entry.

Without disease ID
  • A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:21295283}. Note=The disease is caused by variants affecting the gene represented in this entry.
  • An autosomal dominant neurodevelopmental disorder characterized by global developmental delay, variable intellectual disability, and early-onset seizures with a myoclonic component. Most patients have delayed motor development and show abnormal movements, including ataxia, dystonia, and tremor. {ECO:0000269|PubMed:29100083}. Note=The disease may be caused by variants affecting the gene represented in this entry.

1 regional properties for A5D7I4

Type Name Position InterPro Accession
conserved_site Di-trans-poly-cis-decaprenylcistransferase-like, conserved site 201 - 218 IPR018520

Functions

Description
EC Number 2.4.1.225 Hexosyltransferases
Subcellular Localization
  • Golgi apparatus membrane ; Single-pass type II membrane protein
  • Golgi apparatus, cis-Golgi network membrane ; Single-pass type II membrane protein
  • Endoplasmic reticulum membrane ; Single-pass type II membrane protein
  • The active heparan sulfate polymerase complex composed of EXT1 and EXT2 is localized to the Golgi apparatus
  • If both proteins are individually detected in the endoplasmic reticulum, the formation of the complex promotes their transport to the Golgi
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
Golgi apparatus A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways.
Golgi membrane The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
integral component of endoplasmic reticulum membrane The component of the endoplasmic reticulum membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
synapse The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.

8 GO annotations of molecular function

Name Definition
acetylglucosaminyltransferase activity Catalysis of the transfer of an N-acetylglucosaminyl residue from UDP-N-acetyl-glucosamine to a sugar.
glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity Catalysis of the reaction: beta-D-glucuronosyl-(1,4)-N-acetyl-alpha-D-glucosaminyl-proteoglycan + UDP-N-acetyl-D-glucosamine = N-acetyl-alpha-D-glucosaminyl-(1,4)-beta-D-glucuronosyl-(1,4)-N-acetyl-alpha-D-glucosaminyl-proteoglycan + UDP.
glucuronosyltransferase activity Catalysis of the reaction: UDP-glucuronate + acceptor = UDP + acceptor beta-D-glucuronoside.
glycosyltransferase activity Catalysis of the transfer of a glycosyl group from one compound (donor) to another (acceptor).
metal ion binding Binding to a metal ion.
N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity Catalysis of the reaction: N-acetyl-alpha-D-glucosaminyl-(1,4)-beta-D-glucuronosyl-proteoglycan + UDP-alpha-D-glucuronate = beta-D-glucuronosyl-(1,4)-N-acetyl-alpha-D-glucosaminyl-(1,4)-beta-D-glucuronosyl-proteoglycan + UDP.
protein heterodimerization activity Binding to a nonidentical protein to form a heterodimer.
protein homodimerization activity Binding to an identical protein to form a homodimer.

77 GO annotations of biological process

Name Definition
antigen processing and presentation The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
axon guidance The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
basement membrane organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the basement membrane.
blood vessel remodeling The reorganization or renovation of existing blood vessels.
BMP signaling pathway The series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
bone resorption The process in which specialized cells known as osteoclasts degrade the organic and inorganic portions of bone, and endocytose and transport the degradation products.
canonical Wnt signaling pathway The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
cartilage development involved in endochondral bone morphogenesis The process whose specific outcome is the progression of the cartilage that will provide a scaffold for mineralization of endochondral bones.
cell adhesion mediated by integrin The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits.
cell fate commitment The commitment of cells to specific cell fates and their capacity to differentiate into particular kinds of cells. Positional information is established through protein signals that emanate from a localized source within a cell (the initial one-cell zygote) or within a developmental field.
cellular response to virus Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.
chondrocyte hypertrophy The growth of a chondrocyte, where growth contributes to the progression of the chondrocyte over time.
chondrocyte proliferation The multiplication or reproduction of chondrocytes by cell division, resulting in the expansion of their population. A chondrocyte is a polymorphic cell that forms cartilage.
chondroitin sulfate metabolic process The chemical reactions and pathways involving chondroitin sulfate, any member of a group of 10-60 kDa glycosaminoglycans, widely distributed in cartilage and other mammalian connective tissues, the repeat units of which consist of beta-(1,4)-linked D-glucuronyl beta-(1,3)-N-acetyl-D-galactosamine sulfate. They usually occur linked to a protein to form proteoglycans. Two subgroups exist, one in which the sulfate is on the 4-position (chondroitin sulfate A) and the second in which it is in the 6-position (chondroitin sulfate C). They often are polydisperse and often differ in the degree of sulfation from tissue to tissue. The chains of repeating disaccharide are covalently linked to the side chains of serine residues in the polypeptide backbone of a protein by a glycosidic attachment through the trisaccharide unit galactosyl-galactosyl-xylosyl. Chondroitin sulfate B is more usually known as dermatan sulfate.
collagen fibril organization Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
cranial skeletal system development The process whose specific outcome is the progression of a cranial skeletal system over time, from its formation to the mature structure. The cranial skeletal system is the skeletal subdivision of the head, and includes the skull (cranium plus mandible), pharyngeal and/or hyoid apparatus.
dendrite self-avoidance The process in which dendrites recognize and avoid contact with sister dendrites from the same cell.
dendritic cell migration The movement of a dendritic cell within or between different tissues and organs of the body.
developmental growth involved in morphogenesis The increase in size or mass of an anatomical structure that contributes to the structure attaining its shape.
embryonic skeletal joint development The process, occurring during the embryonic phase, whose specific outcome is the progression of the skeletal joints over time, from formation to mature structure.
endochondral bone growth The increase in size or mass of an endochondral bone that contributes to the shaping of the bone.
endochondral ossification Replacement ossification wherein bone tissue replaces cartilage.
endoderm development The process whose specific outcome is the progression of the endoderm over time, from its formation to the mature structure. The endoderm is the innermost germ layer that develops into the gastrointestinal tract, the lungs and associated tissues.
epithelial tube branching involved in lung morphogenesis The process in which a highly ordered sequence of patterning events generates the branched epithelial tubes of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units.
fear response The response of an organism to a perceived external threat.
fibroblast growth factor receptor signaling pathway The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
fluid transport The directed movement of substances that are in liquid form in normal living conditions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
gastrulation A complex and coordinated series of cellular movements that occurs at the end of cleavage during embryonic development of most animals. The details of gastrulation vary from species to species, but usually result in the formation of the three primary germ layers, ectoderm, mesoderm and endoderm.
gene expression The process in which a gene's sequence is converted into a mature gene product (protein or RNA). This includes the production of an RNA transcript and its processing, translation and maturation for protein-coding genes.
glandular epithelial cell differentiation The process in which a relatively unspecialized cell acquires specialized features of a glandular epithelial cell. A glandular epithelial cell is a columnar/cuboidal epithelial cell found in a two dimensional sheet with a free surface exposed to the lumen of a gland.
glomerular basement membrane development The process whose specific outcome is the progression of the glomerular basement membrane over time, from its formation to the mature structure. The glomerular basement membrane is the basal laminal portion of the glomerulus which performs the actual filtration.
hair follicle morphogenesis The process in which the anatomical structures of the hair follicle are generated and organized.
heart contraction The multicellular organismal process in which the heart decreases in volume in a characteristic way to propel blood through the body.
heart field specification The process that results in the delineation of a specific region of the lateral mesoderm into the area in which the heart will develop.
hematopoietic stem cell differentiation The process in which a relatively unspecialized cell acquires specialized features of a hematopoietic stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
hematopoietic stem cell homeostasis Any biological process involved in the maintenance of the steady-state number of hematopoietic stem cells within a population of cells.
hematopoietic stem cell migration to bone marrow The orderly movement of a hematopoietic stem cell into the bone marrow, and its subsequent positioning within defined functional compartments in that microenvironment. A hematopoietic stem cell is a cell from which all cells of the lymphoid and myeloid lineages develop, including blood cells and cells of the immune system.
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process The chemical reactions and pathways resulting in the formation of polysaccharide chain component of heparan sulfate proteoglycan.
heparin biosynthetic process The chemical reactions and pathways resulting in the formation of heparin, any member of a group of glycosaminoglycans of average Mr (6000-20000), consisting predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
hypersensitivity An inflammatory response to an exogenous environmental antigen or an endogenous antigen initiated by the adaptive immune system.
leukocyte tethering or rolling Transient adhesive interactions between leukocytes and endothelial cells lining blood vessels. Carbohydrates on circulating leukocytes bind selectins on the vessel wall causing the leukocytes to slow down and roll along the inner surface of the vessel wall. During this rolling motion, transitory bonds are formed and broken between selectins and their ligands. Typically the first step in cellular extravasation (the movement of leukocytes out of the circulatory system, towards the site of tissue damage or infection).
limb joint morphogenesis The process in which the anatomical structures of a limb joint are generated and organized. A limb joint is a flexible region that separates the rigid sections of a limb to allow movement in a controlled manner.
lymphocyte adhesion to endothelial cell of high endothelial venule The attachment of a lymphocyte to an endothelial cell of a high endothelial venule (HEV) via adhesion molecules. A HEV cell is an endothelial cell that is cuboidal, expresses leukocyte-specific receptors, and allows for passage of lymphocytes into bloodstream.
lymphocyte migration into lymphoid organs The movement of a lymphocyte within the lymphatic system into lymphoid organs such as lymph nodes, spleen or Peyer's patches, and its subsequent positioning within defined functional compartments such as sites of cell activation by antigen.
mesenchymal cell differentiation involved in bone development The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the mesenchymal cells of bone as it progresses from its formation to the mature state.
mesoderm development The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
motor behavior The specific neuromuscular movement of a single organism in response to external or internal stimuli.
multicellular organism growth The increase in size or mass of an entire multicellular organism, as opposed to cell growth.
multicellular organismal water homeostasis Any process involved in the maintenance of an internal steady state of water within a tissue, organ, or a multicellular organism.
neural crest cell differentiation The process in which a relatively unspecialized cell acquires specialized features of a neural crest cell.
olfactory bulb development The progression of the olfactory bulb over time from its initial formation until its mature state. The olfactory bulb coordinates neuronal signaling involved in the perception of smell. It receives input from the sensory neurons and outputs to the olfactory cortex.
optic nerve development The process whose specific outcome is the progression of the optic nerve over time, from its formation to the mature structure. The sensory optic nerve originates from the bipolar cells of the retina and conducts visual information to the brainstem. The optic nerve exits the back of the eye in the orbit, enters the optic canal, and enters the central nervous system at the optic chiasm (crossing) where the nerve fibers become the optic tract just prior to entering the hindbrain.
ossification involved in bone maturation The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone, involved in the progression of the skeleton from its formation to its mature state.
perichondral bone morphogenesis The process in which bones are generated and organized as a result of the conversion of initial connective tissue surrounding cartilage into bone.
podocyte differentiation The process in which a relatively unspecialized cell acquires specialized features of a glomerular visceral epithelial cell. A glomerular visceral epithelial cell is a specialized epithelial cell that contains 'feet' that interdigitate with the 'feet' of other glomerular epithelial cells.
protein catabolic process The chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
protein glycosylation A protein modification process that results in the addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid, e.g. the addition of glycan chains to proteins.
protein-containing complex assembly The aggregation, arrangement and bonding together of a set of macromolecules to form a protein-containing complex.
regulation of blood pressure Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
response to heparin Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heparin stimulus.
response to leukemia inhibitory factor Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leukemia inhibitory factor stimulus.
response to light intensity Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a light intensity stimulus.
sebaceous gland development The process whose specific outcome is the progression of the sebaceous gland over time, from its formation to the mature structure.
smoothened signaling pathway involved in lung development The series of molecular signals generated as a consequence of activation of the transmembrane Smoothened-type protein. This process contributes to lung development.
social behavior Behavior directed towards society, or taking place between members of the same species. Occurs predominantly, or only, in individuals that are part of a group.
sodium ion homeostasis Any process involved in the maintenance of an internal steady state of sodium ions within an organism or cell.
stem cell division The self-renewing division of a stem cell. A stem cell is an undifferentiated cell, in the embryo or adult, that can undergo unlimited division and give rise to one or several different cell types.
stomach development The process whose specific outcome is the progression of the stomach over time, from its formation to the mature structure. The stomach is an expanded region of the vertebrate alimentary tract that serves as a food storage compartment and digestive organ.
sulfation The addition of a sulfate group to a molecule.
sweat gland development The progression of the sweat gland over time, from its formation to the mature structure. Sweat glands secrete an aqueous solution that is used in thermoregulation.
synaptic transmission, glutamatergic The vesicular release of glutamate from a presynapse, across a chemical synapse, the subsequent activation of glutamate receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse.
tight junction organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a tight junction. A tight junction seals cells together in an epithelium in a way that prevents even small molecules from leaking from one side of the sheet to the other.
TNFSF11-mediated signaling pathway The series of molecular signals initiated by the binding of tumor necrosis factor ligand superfamily member 11 (TNFSF11) to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
vacuole organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a vacuole.
vasodilation An increase in the internal diameter of blood vessels, especially arterioles or capillaries, due to relaxation of smooth muscle cells that line the vessels, and usually resulting in a decrease in blood pressure.
vocalization behavior The behavior in which an organism produces sounds by a mechanism involving its respiratory system.
wound healing The series of events that restore integrity to a damaged tissue, following an injury.

10 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O77783 EXT2 Exostosin-2 Bos taurus (Bovine) PR
Q16394 EXT1 Exostosin-1 Homo sapiens (Human) PR
P97464 Ext1 Exostosin-1 Mus musculus (Mouse) PR
Q10SX7 Os03g0107900 Probable glucuronosyltransferase Os03g0107900 Oryza sativa subsp japonica (Rice) PR
O01704 rib-1 Exostosin-1 homolog Caenorhabditis elegans PR
Q94AA9 XGD1 Xylogalacturonan beta-1,3-xylosyltransferase Arabidopsis thaliana (Mouse-ear cress) PR
Q9LFP3 At5g11130/At5g11120 Probable glycosyltransferase At5g11130 Arabidopsis thaliana (Mouse-ear cress) PR
Q3EAR7 At3g42180 Probable glycosyltransferase At3g42180 Arabidopsis thaliana (Mouse-ear cress) PR
Q5IGR8 ext1a Exostosin-1a Danio rerio (Zebrafish) (Brachydanio rerio) PR
Q5IGR7 ext1b Exostosin-1b Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MQAKKRYFIL LSAGSCLALL FYFGGLQFRA SRSHSRREEH SGRNGLHHPS PDHFWPRFPD
70 80 90 100 110 120
ALRPFVPWDQ LENEDSSVHV SPRQKREANS SIYKGKKCRM ESCFDFTLCK KNGFKVYVYP
130 140 150 160 170 180
QQKGEKIAES YQNILAAIEG SRFYTSDPSQ ACLFVLSLDT LDRDQLSPQY VHNLRSKVQS
190 200 210 220 230 240
LHLWNNGRNH LIFNLYSGTW PDYTEDVGFD IGQAMLAKAS ISTENFRPNF DVSIPLFSKD
250 260 270 280 290 300
HPRTGGERGF LKFNTIPPLR KYMLVFKGKR YLTGIGSDTR NALYHVHNGE DVVLLTTCKH
310 320 330 340 350 360
GKDWQKHKDS RCDRDNTEYE KYDYREMLHN ATFCLVPRGR RLGSFRFLEA LQAACVPVML
370 380 390 400 410 420
SNGWELPFSE VINWNQAAVI GDERLLLQIP STIRSIHQDK ILALRQQTQF LWEAYFSSVE
430 440 450 460 470 480
KIVLTTLEII QDRIFKHISR NSLIWNKHPG GLFVLPQYSS YLGDFPYYYA NLGLKPPSKF
490 500 510 520 530 540
TAVIHAVTPL VSQSQPVLKL LVAAAKSQYC AQIIVLWNCD KPLPAKHRWP ATSVPVIVIE
550 560 570 580 590 600
GESKVMSSRF LPYDNIITDA VLSLDEDTVL STTEVDFAFT VWQSFPERIV GYPARSHFWD
610 620 630 640 650 660
NSKERWGYTS KWTNDYSMVL TGAAIYHKYY HYLYTHYLPA SLKNMVDQLA NCEDILMNFL
670 680 690 700 710 720
VSAVTKLPPI KVTQKKQYKE TMMGQTSRAS RWADPDHFAQ RQSCMNTFAS WFGYMPLIHS
730 740
QMRLDPVLFK DQVSILRKKY RDIERL